arrow
L

Letizia Leocani

San Raffaele University
H指数:60
被引数:1.6万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Subclinical Optic Nerve Involvement in Radiologically Isolated Syndrome: Multimodal Detection and Diagnostic Impact

放射学孤立综合征中临床前视神经受累:多模态检测与诊断影响

2026-06-020
OAAI
Digital patient experience tools in multiple sclerosis: a landscape analysis of the global Patient-Reported Outcomes in Multiple Sclerosis (PROMS) initiative

数字患者体验工具在多发性硬化症中的应用:全球多发性硬化症患者报告结局(PROMS)倡议的景观分析

2026-03-190
OAAI
Lessons Learned: Quality Analysis of Optical Coherence Tomography in Neuromyelitis Optica
2025-11-010
OAAI
APOSTEL-R Recommendations for Reporting Retinal Optical Coherence Tomography Studies in Rodents
2025-11-010
PRE
The use of optical coherence tomography and visual evoked potentials in the 2024 McDonald diagnostic criteria for multiple sclerosis

光学相干断层扫描和视觉诱发电位在2024年McDonald多发性硬化诊断标准中的应用

2025-09-170
PRE
Clinical and mechanistic effects of cladribine in relapsing multiple sclerosis: 2-year results from the MAGNIFY-MS Study

克拉屈滨在复发型多发性硬化中的临床和机制性作用:MAGNIFY-MS研究2年结果

2025-07-310
OA
Summary of Research: Blood Biomarker Dynamics in People with Relapsing Multiple Sclerosis Treated with Cladribine Tablets: Results of the 2-Year MAGNIFY-MS Study

研究总结:接受克拉屈滨片治疗复发型多发性硬化患者的血液生物标志物动态变化:MAGNIFY-MS研究2年结果

2025-07-040
OAAI
Blood biomarker dynamics in people with relapsing multiple sclerosis treated with cladribine tablets: results of the 2-year MAGNIFY-MS study

克拉屈滨片治疗复发性多发性硬化症患者的血液生物标志物动态: 2年MAGNIFY-MS研究结果

2025-02-030
OAAI